Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Santarus

Biotech & Life Sciences · San Diego, United States · Founded 1996 · IPO 2004 Unicorn

A specialty biopharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by physician specialists

Investors

9 investors on Santarus's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 9 investors entered at this stage
Windamere Venture Partners
New England Partners
Domain Associates
Advent Venture Partners
EQT Life Sciences
Fog City Capital
JP Morgan
CDIB Capital Group
St. Paul Venture Capital

Global footprint

Where Santarus has talent and traffic

Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Patent intelligence

$4M patent portfolio · 2 active families

Estimated portfolio value
$4M
1864.7× smaller than top peer Janssen Vaccines ($7.1B)
2 active patent families
Where Santarus innovates Proton-pump inhibitorProton pumpGastrointestinal disorderGastric acidDrug

Where Santarus concentrates vs peers

Each axis is a top-10 topic across Santarus and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Santarus

An AI-synthesized read of the highest-engagement posts about Santarus on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Santarus on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.